Kashi Clinical Laboratories can give breadth and flexibility to your genetic analysis using targeted sequencing technologies on the Ion Torrent or Illumina platforms. Targeted sequencing enables scientists to pinpoint and magnify specific regions within the human genome. Such targeted analysis is ideal for clinical research by increasing cost-effectiveness, throughput, and scalability.
There are a number of applications for targeted sequencing, including the detection of various genetic aberrations such as single-nucleotide polymorphisms (SNP’s), insertions and deletions (indels), copy number variants (CNV’s), and genetic rearrangements. Some applications include cancer genomics, and inherited genetic disease/disorder research – including analysis of FFPE (formalin-fixed paraffin-embedded) tissue samples.
NGS platforms available in the laboratory include the Ion Torrent S5, Proton and PGM, and the Illumina MiSeq. Targeted gene panels with either preselected content or custom designed to include genomic regions of interest can be quickly validated and tailored to your individual laboratory’s needs.
Targeted Sequencing Panels Offered by Kashi Genomics
- For a focused and cost effective approach to identifying solid tumor variants, the Oncomine™ Focus Assay targets hotspots, SNVs, indels, and CNVs across 52 genes relevant to solid tumors.
- To target specific genomic regions of interest, the Kashi Genomics team is poised to develop custom-design Ampliseq Panels to provide a cost-effective laboratory solution that is tailored to your specific project.